Eric H. Raabe, Ph.D.
Affiliations: | 2002 | University of Cincinnati, Cincinnati, OH |
Area:
Molecular Biology, Cell BiologyGoogle:
"Eric Raabe"Parents
Sign in to add mentorRobert Arceci | grad student | 2002 | University of Cincinnati | |
(Functional and biochemical analysis of a novel SNF2 factor.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Duchatel RJ, Jackson ER, Parackal SG, et al. (2024) PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma. The Journal of Clinical Investigation |
Sun CX, Daniel P, Bradshaw G, et al. (2023) Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities. Cancer Cell |
Parkhurst A, Wang SZ, Findlay TR, et al. (2022) Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors. Cell Death & Disease. 13: 410 |
Pham K, Hanaford AR, Poore BA, et al. (2022) Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways. Cancers. 14 |
Maxwell MJ, Arnold A, Sweeney H, et al. (2021) Unbiased proteomic and phosphoproteomic analysis identifies response signatures and novel susceptibilities after combined MEK and mTOR inhibition in BRAF mutant glioma. Molecular & Cellular Proteomics : McP. 100123 |
Nakata S, Yuan M, Rubens JA, et al. (2021) BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets. International Journal of Molecular Sciences. 22 |
Pham K, Maxwell MJ, Sweeney H, et al. (2021) Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis. Journal of Neuropathology and Experimental Neurology |
Maynard R, Poore B, Hanaford AR, et al. (2021) TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. Cancer Letters |
Garcia-Moure M, Gonzalez-Huarriz M, Labiano S, et al. (2020) Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Shahab S, Rubens J, Kaur H, et al. (2020) MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors. Journal of Neuropathology and Experimental Neurology |